{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:37:41Z","timestamp":1774485461341,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1994,10]]},"abstract":"<jats:p>5-Aminosalicylic acid (5-ASA) has structural similarities to both phenacetin and aspirin, which are known to cause 'analgesic nephropathy'. Because of the increasing use of 5-ASA, this paper draws attention to two cases of severe interstitial nephritis resulting from 5-ASA and emphasises the importance of monitoring renal functions of patients with inflammatory bowel diseases who are receiving 5-ASA preparations.<\/jats:p>","DOI":"10.1136\/gut.35.10.1493","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"1493-1496","source":"Crossref","is-referenced-by-count":57,"title":["Mesalazine induced interstitial nephritis."],"prefix":"10.1136","volume":"35","author":[{"given":"P J","family":"Thuluvath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ninkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Calam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1994,10,1]]},"reference":[{"key":"ref_1","first-page":"2191","article-title":"Chronic tubulointerstitial nephropathies. In Schrier RW, Gottschalk CW, eds. Diseases of the kidney","author":"Eknoyan, G.","year":"1988","unstructured":"Eknoyan G. Chronic tubulointerstitial nephropathies. In Schrier RW, Gottschalk CW, eds. Diseases of the kidney. Toronto: Little, Brown, 1988; 2191-221."},{"key":"ref_2","first-page":"65","article-title":"Analgesic nephrotoxicity and renal papillary necrosis","volume":"4","author":"Eknoyan, G.","year":"1984","unstructured":"Eknoyan G. Analgesic nephrotoxicity and renal papillary necrosis. Semin Nephrol 1984; 4: 65-76.","journal-title":"Semin Nephrol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198302173080703","article-title":"Epidemiologic study of abuse of analgesic containing phenacetin. Renal morbidity and mortality","volume":"308","author":"Dubach, U.C.; Rosner, B.; Pfister, E.","year":"1986","unstructured":"Dubach UC, Rosner B, Pfister E. Epidemiologic study of abuse of analgesic containing phenacetin. Renal morbidity and mortality (1986-1979). N Eng J Med 1983; 308: 357-62.","journal-title":"N Eng J Med"},{"key":"ref_4","first-page":"310","article-title":"Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl Jf Med 1984; less than Asacol and similar compounds. This may result from incomplete release of 5-ASA","author":"Clive, D.M.; Stoff, J.S.","unstructured":"Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl Jf Med 1984; less than Asacol and similar compounds. This may result from incomplete release of 5-ASA 310: 563-72."},{"key":"ref_5","first-page":"152","article-title":"Nephrotoxicity lesion from 5-aminosalicylic acid. BMJ from the granules26; or perhaps because the slow delivery does not overwhelm the","volume":"1","author":"Calder, I.C.; Funder, C.C.; Green, C.R.; Ham, K.N.; Tange, J.D.","year":"1972","unstructured":"Calder IC, Funder CC, Green CR, Ham KN, Tange JD. Nephrotoxicity lesion from 5-aminosalicylic acid. BMJ from the granules26; or perhaps because the slow delivery does not overwhelm the 1972; 1: 152-4."},{"key":"ref_6","first-page":"77","article-title":"N-acetyl-D glucosaminidase (NAG) and alanine aminopeptidase (AAP) excretion after acute administration of acetaminophen, salsalate and aspirin in rats","volume":"81","author":"Casadevall, G.; Moreno, J.J.; Franch, M.A.; Queralt, J.","year":"1983","unstructured":"Casadevall G, Moreno JJ, Franch MA, Queralt J. N-acetyl-D glucosaminidase (NAG) and alanine aminopeptidase (AAP) excretion after acute administration of acetaminophen, salsalate and aspirin in rats. Res Commun Chem Pathol Pharmacol 1983; 81: 77-89.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.1980.173","article-title":"Mechanisms in the development of analgesic nephropathy","volume":"18","author":"Duggin, G.G.","year":"1980","unstructured":"Duggin GG. Mechanisms in the development of analgesic nephropathy. Kidney Int 1980; 18: 553-61.","journal-title":"Kidney Int"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM197912063012306","article-title":"Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs","volume":"301","author":"Brezin, J.H.; Katz, S.M.; Schwartz, A.B.; Chinitz, J.L.","year":"1979","unstructured":"Brezin JH, Katz SM, Schwartz AB, Chinitz JL. Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1979; 301: 1271-3.","journal-title":"N Engl J Med"},{"key":"ref_9","first-page":"81","article-title":"Fenprofen nephropathy: lipoid nephrosis and interstitial nephritis: a possible T-lymphocyte disorder","volume":"72","author":"Finkelstein, A.; Fraley, D.S.; Stachura, I.; Feldman, H.A.; Gandy, D.R.; Bourke, E.","year":"1982","unstructured":"Finkelstein A, Fraley DS, Stachura I, Feldman HA, Gandy DR, Bourke E. Fenprofen nephropathy: lipoid nephrosis and interstitial nephritis: a possible T-lymphocyte disorder. Am JMed 1982; 72: 81-7.","journal-title":"Am JMed"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archinte.1978.03630320074025","article-title":"Hypersensitivity to salicylazosulfapyridine. Renal and hepatic toxic reactions","volume":"138","author":"Chester, A.C.; Diamond, L.H.; Schreiner, G.E.","year":"1978","unstructured":"Chester AC, Diamond LH, Schreiner GE. Hypersensitivity to salicylazosulfapyridine. Renal and hepatic toxic reactions. Arch Intern Med 1978; 138: 1138-9.","journal-title":"Arch Intern Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/bmj.301.6755.818-b","article-title":"Nephrotic syndrome associated with sulphasalazine","volume":"301","author":"Barbour, V.M.; Williams, P.F.","year":"1990","unstructured":"Barbour VM, Williams PF. Nephrotic syndrome associated with sulphasalazine. BMJ 1990; 301: 818.","journal-title":"BMJ"},{"key":"ref_12","first-page":"1031","article-title":"Acute interstitial nephritis","volume":"143","author":"Mehta, R.P.","year":"1990","unstructured":"Mehta RP. Acute interstitial nephritis. Can Med Assoc J 1990; 143: 1031-2.","journal-title":"Can Med Assoc J"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.296.6634.1442","article-title":"Nephrotic syndrome after treatment with 5-aminosalicylic acid","volume":"296","author":"Novis, B.H.; Korzets, Z.; Chen, P.; Berheim, J.","year":"1988","unstructured":"Novis BH, Korzets Z, Chen P, Berheim J. Nephrotic syndrome after treatment with 5-aminosalicylic acid. BMJr 1988; 296: 1442.","journal-title":"BMJr"},{"key":"ref_14","first-page":"262","article-title":"Akute interstitielle nephritis durch 5-aminosalicylsaure","volume":"30","author":"Ruf-Ballauf, W.; Hofstadter, F.; Krentz, F.","year":"1989","unstructured":"Ruf-Ballauf W, Hofstadter F, Krentz F. Akute interstitielle nephritis durch 5-aminosalicylsaure. Internist 1989; 30: 262-4.","journal-title":"Internist"},{"key":"ref_15","first-page":"1091","article-title":"Chronische interstitielle Nephritis nach Behandlung mit 5-aminosalicylaure","volume":"114","author":"Henning, H.V.; Meinhold, J.; Eisenhauer, T.; Scheler, F.","year":"1989","unstructured":"Henning HV, Meinhold J, Eisenhauer T, Scheler F. Chronische interstitielle Nephritis nach Behandlung mit 5-aminosalicylaure. Dtsch Med Wochenschr 1989; 114: 1091.","journal-title":"Dtsch Med Wochenschr"},{"key":"ref_16","first-page":"236","article-title":"Nephritis durch 5 amino-salicylsaure","volume":"114","author":"KE, Von Muhlendahl","year":"1989","unstructured":"Von Muhlendahl KE. Nephritis durch 5 amino-salicylsaure. Dtsch Med Wochenschr 1989; 114: 236.","journal-title":"Dtsch Med Wochenschr"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/cs0780105","article-title":"Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells","volume":"78","author":"Ireland, A.; Priddle, J.D.; Jewell, D.P.","year":"1990","unstructured":"Ireland A, Priddle JD, Jewell DP. Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells. Clin Sci 1990; 78: 105-11.","journal-title":"Clin Sci"},{"issue":"2","key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(86)90909-5","article-title":"Renal effects of non-steroidal antiinflammatory drugs in chronic glomerular disease","volume":"81","author":"Patrono, C.; Piercucci, A.","year":"1986","unstructured":"Patrono C, Piercucci A. Renal effects of non-steroidal antiinflammatory drugs in chronic glomerular disease. Am Jf Med 1986; 81 (suppl 2B): 71-83.","journal-title":"Am Jf Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF00613458","article-title":"Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance","volume":"29","author":"Reimann, I.W.; Golbs, E.; Fisher, C.","year":"1985","unstructured":"Reimann IW, Golbs E, Fisher C. Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance. Eur J Clin Pharmacol 1985; 29: 435-41.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archinte.1987.00370090150026","article-title":"Salsalate exacerbation of chronic renal insufficiency: relation to inhibition of prostaglandin synthesis","volume":"147","author":"Abraham, P.A.; Stillman, M.T.","year":"1987","unstructured":"Abraham PA, Stillman MT. Salsalate exacerbation of chronic renal insufficiency: relation to inhibition of prostaglandin synthesis. Arch Intern Med 1987; 147: 1674-6.","journal-title":"Arch Intern Med"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/gut.28.2.196","article-title":"Metabolism and urinary excretion of 5aminosalicyclic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract","volume":"28","author":"Myers, B.; Evans, D.N.W.; Rhodes, J.; Evans, B.K.; Hughes, B.R.; Lee, M.G.","year":"1987","unstructured":"Myers B, Evans DNW, Rhodes J, Evans BK, Hughes BR, Lee MG, et al. Metabolism and urinary excretion of 5aminosalicyclic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract. Gut 1987; 28: 196-200.","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2125.1983.tb02254.x","article-title":"Kinetics of 5-aminosalicyclic acid after jejunal instillation in man","volume":"16","author":"Nielson, O.H.; Bondensen, S.","year":"1983","unstructured":"Nielson OH, Bondensen S. Kinetics of 5-aminosalicyclic acid after jejunal instillation in man. Br J Clin Pharmacol 1983; 16: 738-40.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2036.1990.tb00499.x","article-title":"Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man","volume":"4","author":"Christensen, L.A.; Fallinborg, J.; Abildgaard, K.; Jacobsen, B.A.; Sanchez, G.; Hansen, S.H.","year":"1990","unstructured":"Christensen LA, Fallinborg J, Abildgaard K, Jacobsen BA, Sanchez G, Hansen SH, et al. Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man. Aliment Pharmacol Ther 1990; 4: 523-33.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref_24","first-page":"1062","article-title":"Bondesen 5, Hvidberg EF, Hansen SH, Binder V, Haiskov 5, et al. 5-aminosalicylic acid in a slow release preparation: bioavailability, plasma level","volume-title":"and excretion in humans. Gastroenterology 1982; 83","author":"Rasmussen, S.N.","unstructured":"Rasmussen SN, Bondesen 5, Hvidberg EF, Hansen SH, Binder V, Haiskov 5, et al. 5-aminosalicylic acid in a slow release preparation: bioavailability, plasma level and excretion in humans. Gastroenterology 1982; 83: 1062-70."},{"key":"ref_25","first-page":"400","article-title":"Topical administration of 5-aminosalicyclic acid enemas in patients with ulcerative colitis: studies on rectal absorption and excretion","volume":"5","author":"Campieri, M.; Lanfranchi, G.A.","year":"1985","unstructured":"Campieri M, Lanfranchi GA, Boschi 5, Brignola C, Bazzocchi G, Gionchetti P, et al. Topical administration of 5-aminosalicyclic acid enemas in patients with ulcerative colitis: studies on rectal absorption and excretion. Gut 1985; 26: 400-5.","journal-title":"Boschi"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/00365521.1984.12005793","article-title":"5-aminosalicylic acid enemas in patients with active ulcerative colitis: influence of acidity on the kinetic pattern","volume":"19","author":"true","year":"1984","unstructured":"Bondesen S, Nielsen OH, Jacobsen 0, Rasmussen SN, Hansen SH, Halskov S, et al. 5-aminosalicylic acid enemas in patients with active ulcerative colitis: influence of acidity on the kinetic pattern. Scand Jf Gastroenterol 1984; 19: 677-82.","journal-title":"Scand Jf Gastroenterol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3109\/00365528909090784","article-title":"Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid delivering drugs during accelerated intestinal transit in healthy volunteers","volume":"24","author":"Rijk, M.C.M.; Van Hogezand, R.A.; Van Schaik, A.; Van Tongren, J.H.M.","year":"1989","unstructured":"Rijk MCM, Van Hogezand RA, Van Schaik A, Van Tongren JHM. Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid delivering drugs during accelerated intestinal transit in healthy volunteers. Scand J Gastroenterol 1989; 24: 1179-85.","journal-title":"Scand J Gastroenterol"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00365528809093858","article-title":"Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid delivery compounds","volume":"23","author":"Rijk, M.C.M.; Van Schaik, A.; Van Tongeren, J.H.M.","year":"1988","unstructured":"Rijk MCM, Van Schaik A, Van Tongeren JHM. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid delivery compounds. ScandJ Gastroenterol 1988; 23: 107-12.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/gut.31.11.1271","article-title":"Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion","volume":"31","author":"Laursen, L.S.; Stokholm, M.; Bukhave, K.; Rask-Madsen, J.; Lauritsen, K.","year":"1990","unstructured":"Laursen LS, Stokholm M, Bukhave K, Rask-Madsen J, Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut 1990; 31: 1271-6.","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/jps.2600681036","article-title":"Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulphasalazine, in rats","volume":"68","author":"Pieniaszek, H.J.; Bates, T.R.","year":"1979","unstructured":"Pieniaszek HJ, Bates TR. Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulphasalazine, in rats. J Pharm Sci 1979; 68: 1323-5.","journal-title":"J Pharm Sci"},{"key":"ref_31","article-title":"Analgesic associated nephropathy","volume-title":"Textbook of nephrology","author":"Nanra, R.S.","year":"1983","unstructured":"Nanra RS. Analgesic associated nephropathy. In: Massry SG, Glassock RJ, eds. Textbook of nephrology. Baltimore: Williams & Wilkins, 1983; 6.195-201."}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.35.10.1493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:41:56Z","timestamp":1765611716000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.35.10.1493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[1994,10,1]]},"published-print":{"date-parts":[[1994,10]]}},"alternative-id":["10.1136\/gut.35.10.1493"],"URL":"https:\/\/doi.org\/10.1136\/gut.35.10.1493","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}